BIIB
BIOGEN INC.Compliant · 70/100
Sector: Healthcare · Industry: Biotechnology · Data as of 2026-02-06
Screening standard
The evidence
| Test | Figure | Limit | Source |
|---|---|---|---|
| Passed: Business activityBusiness activity is compliant. | compliant | ||
| Passed: Debt vs. market capinterest-bearing debt / market cap = 25.85% (< 33% limit). | 25.85% | < 33.00% | |
| Passed: Interest income vs. revenueinterest income / total revenue = 1.26% (< 5% limit). | 1.26% | < 5.00% | |
| Passed: Cash & interest-bearing assets vs. market cap(cash + interest-bearing securities) / market cap = 25.02% (< 33% limit). | 25.02% | < 33.00% |
Every number, sourced
Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.
| Figure | Value | Source |
|---|---|---|
| Total revenueRevenues | $9.9B | |
| Interest-bearing debtLong term debt | $6.3B | |
| Cash & interest-bearing securities3 components | $6.1B | |
| Interest incomeInvestment income interest | $125.0M | |
| Total assetsAssets | $29.4B | |
| ReceivablesAccounts receivable net current | $1.3B | |
| Shares outstandingEntity common stock shares outstanding | 147.6M shares | |
| Priceyahoo:24mo-trailing-avg | $164.752 |
Dividend purification
Est. 1.26% of dividends should be purified.
Price
Values & Controversies
Separate from the shariah verdict above — always.
No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we line.